Indefinite Delivery Contract SPE2DP26D0006
Award Date 2/6/26
Last Date to Order 2/5/27
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Seqirus USA Inc. has been awarded a single-award Indefinite Delivery Contract valued at $2.26 million by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency, with an award date of February 4, 2026, and an ultimate completion date of February 3, 2027. This contract does not utilize any set-aside designations and represents the prime contractor's continued engagement with the federal government to supply injectable influenza vaccines for the 2026-2027 flu season....
- Seqirus USA Inc. holds a Federal Supply Schedule contract (FSS-61-IB) under the Pharmaceuticals and Drugs category awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 12, with a ceiling value of $2.56 million and an ultimate completion date of August 31, 2029. The contract was awarded on September 1, 2024, as a multiple-award indefinite delivery vehicle without set-aside designation. The primary scope encompasses influenza vaccines and related hematology...
- Seqirus USA Inc., headquartered in Summit, New Jersey, was awarded a single-award Indefinite Delivery Contract valued at $30.9 million by the Department of Veterans Affairs National Acquisition Center for the supply of influenza virus vaccines during the 2026-2027 flu season. The contract, effective from March 15, 2026, through March 14, 2027, covers the procurement of various influenza vaccine formulations including quadrivalent vaccines, multi-dose vials, pre-filled syringes, and specialized...
- The Centers for Disease Control and Prevention (CDC) awarded a multiple-award Indefinite Delivery Contract valued at $86.5 million to Seqirus USA Inc. for the procurement of adult influenza vaccines through February 28, 2027. This civilian federal contract, awarded on December 31, 2025, utilizes no set-aside designations and represents part of the CDC's broader vaccine procurement strategy under its Major Program Code for Vaccines. Seqirus USA Inc., headquartered in Summit, New Jersey, is a...
- The Defense Logistics Agency Troop Support Medical awarded a single award indefinite delivery contract to Seqirus USA Inc. for the supply of injectable influenza virus vaccines. The potential value of the contract vehicle is $22.6 million to be delivered between February 2021 through February 2022. Several firm fixed price delivery orders were subsequently issued against this contract for vaccine quantities between $778 to $6.6 million to support the Agency's medical countermeasures programs....
- This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The $27.5M IDC, which has a period of performance through June 2019, aims to procure approximately 3.6 million doses of injectable influenza vaccine in multi-dose vials and pre-filled syringes for various ages, including pediatric formulations. The contract supports...
- The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Seqirus USA Inc. to supply influenza virus vaccines. Under this contract vehicle, multiple firm fixed price delivery orders were issued for vaccine doses valued between $13,975 to over $12 million each. Places of performance are Seqirus' Summit, New Jersey facility. Periods of performance span from March 2023 through October 2023. The original solicitation sought proposals to supply approximately 3.39...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The contract, valued at $36,120,112.50, aims to procure approximately 3.23 million doses of injectable influenza virus vaccines in multi-dose vials and pre-filled syringes for various age groups, including elderly, adult, and pediatric populations. The vaccines are intended...
- This multiple-award Indefinite Delivery Contract, awarded by the Centers for Disease Control and Prevention (CDC) on December 31, 2022, provides adult influenza vaccines for the 2023-2024 flu season with a ceiling value of $146.1 million. The contract was awarded to Seqirus USA Inc., a biotechnology company headquartered in Summit, New Jersey, with no set-aside designation applied. The contract period extends through February 28, 2024, during which the CDC may issue delivery orders on an...
- The Defense Logistics Agency Troop Support Medical awarded a single-award Indefinite Delivery Contract to Seqirus USA Inc. with a potential value of $12,954,518.10 to supply influenza virus vaccinations. Under this contract, three firm fixed price delivery orders have been issued to Seqirus USA Inc. totaling $12,710,418.40 to provide influenza virus vaccinations for the 2022-2023 flu season. The delivery orders require vaccinations be delivered to Summit, New Jersey by August 31, 2022. The...